Has Kevin Rosi, MD received payments from drug or device companies?

Yes. Drug and device makers reported $984 in general payments to Kevin Rosi, MD across 40 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kevin Rosi, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kevin Rosi, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kevin Rosi, MD

Child & Adolescent Psychiatry · Palo Alto, CANPI 1821150954

Payments from drug & device makers

$984in general payments, 2019–2025

Across 40 payments — averaging $24.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$231
Johnson & Johnson$216
Bausch Health US, LLC$115
Otsuka America Pharmaceutical, Inc.$104
Axsome Therapeutics, Inc.$82
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$47
plus $189 from 6 others

What the payments were for

Food & beverage$984100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	10	$231
Johnson & Johnson	7	$216
Bausch Health US, LLC	5	$115
Otsuka America Pharmaceutical, Inc.	4	$104
Axsome Therapeutics, Inc.	3	$82
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	2	$47
Takeda Pharmaceuticals U.S.A., Inc.	3	$45
Neurocrine Biosciences, Inc.	2	$45
Indivior Inc.	1	$38
E.r. Squibb & Sons, L.L.C.	1	$23
Supernus Pharmaceuticals, Inc.	1	$21
Almatica Pharma LLC	1	$17

How this compares

$984 in reported general payments places this provider in the 75th percentile of 434 child & adolescent psychiatry providers in California.

See all child & adolescent psychiatry providers in California →

Medicare billing

Part B allowed, 2024

$111,174

Medicare patients

Services billed

463

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Lisdexamfetamine Dimesylate	13	$3,217
Duloxetine Hcl	13	$581
Bupropion XlBupropion Hcl	21	$421
Buspirone Hcl	15	$374
Trazodone Hcl	19	$317
Venlafaxine Hcl ErVenlafaxine Hcl	20	$270
Quetiapine Fumarate	11	$253
Lurasidone Hcl	16	$249
Lamotrigine	14	$202
Clonazepam	18	$114
Alprazolam	17	$32

Paid to pharmacies, not to this prescriber.

Other child & adolescent psychiatry in Palo Alto

Antonio HardanPalo Alto$160K
Lawrence FungPalo Alto$6K
Shivani ChmuraPalo Alto$2K
Kevin CoxOjai$2.9M
Sarah LeeRiverside$735K
Eliot MoonPasadena$522K
Robert HendrenSan Francisco$486K
Michael McManusSan Diego$426K
Sukhjit BrarFresno$283K
Manpreet SinghSacramento$238K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →